Home » Topics » Regulatory » EMA

EMA
RSS

Roche files to extend indication of tocilizumab for systemic juvenile idiopathic arthritis

Oct. 21, 2010

EC grants orphan drug status for eflornithine in familial adenomatous polyposis

Oct. 21, 2010

EC grants orphan drug status for S*BIO's SB-1518 in myelofibrosis

Oct. 20, 2010

EMA recommends approval of CTI's pediatric investigation plan for Pixuvri

Oct. 20, 2010

European orphan drug status for recombinant porcine factor VIII in hemophilia A

Oct. 20, 2010

EMA grants orphan drug status for forodesine in chronic lymphocytic leukemia

Oct. 19, 2010

EC grants orphan drug status for pralatrexate in Hodgkin's lymphoma

Oct. 19, 2010

European orphan drug status for NeuroSTAT in traumatic brain injury

Oct. 18, 2010

EMA approves Twynsta single pill combination for high blood pressure

Oct. 14, 2010

Tesetaxel receives EMA orphan drug status for gastric cancer

Oct. 14, 2010

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 15, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...